Research Article
Evaluation of the Expression of the Human Epithelial Receptor 2 (HER2) in Gastric Carcinoma
Table 2
Correlation of age, survival time, and lymph node involvement in patients with HER2 expression.
| Characteristic | HER2 | | Absent | Indeterminate | Present |
| Age (years) | = 111 | = 6 | = 4 | 0. | Min = 26 | Min = 60 | Min = 48 | Max = 83 | Max = 89 | Max = 71 | Median = 61.0 | Median = 89.5 | Median = 56.5 | Average = 60.1 | Average = 71.0 | Average = 58.0 | SD = 12.3 | SD = 9.8 | SD = 10.6 |
| Survival time (months) | = 111 | = 6 | = 4 | 0. | Min = 1 | Min = 1 | Min = 4 | Max = 82 | Max = 60 | Max = 46 | Median = 42 | Median = 42.5 | Median = 42.5 | Average = 39.3 | Average = 34.3 | Average = 33.8 | SD = 25.0 | SD = 24.7 | SD = 19.9 |
| Positive lymph nodes | = 111 | = 6 | = 4 | 0. | Min = 0 | Min = 0 | Min = 0 | Max = 64 | Max = 8 | Max = 11 | Median = 1.0 | Median = 4.0 | Median = 8.0 | Average = 5.8 | Average = 3.5 | Average = 6.8 | SD = 10.2 | SD = 3.1 | SD = 4.8 |
|
|
-Wallis variance analysis.
|